CLDX
CLDX
US15117B2025
Celldex Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.545.000 7.020.000
78.0%
Cost of Revenue -- --
--
Gross Profit -- --
--
288.912.000 202.098.000
43.0%
Operating Income -287.367.000 -195.078.000
47.3%
Pretax Income -258.757.000 -157.863.000
63.9%
Net Income Common Stockholders -258.757.000 -157.863.000
63.9%
-- --
--
-- --
--
ende